Toggle Offcanvas
...
 
Carboxymaltose Tenders

Carboxymaltose Tenders

View Carboxymaltose tenders, RFPs and contracts. Bid on readily available Carboxymaltose tenders with the best and most comprehensive tendering platform, since 2002.
Carboxymaltose is an iron supplement given intravenously to treat iron deficiency anemia. It ensures quick replenishment of iron stores, improving energy levels and overall health.

Bidding for Carboxymaltose tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Carboxymaltose.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Carboxymaltose market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Carboxymaltose tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

7 Live Notices for Carboxymaltose Tenders

Showing 1 to 7

Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Iron Carboxymaltose (Atc Code: B03Ac01).
country Germany
posting date09 Jan 2025
deadline28 Dec 2026
Conclusion Not Excluding Drug Discount Agreement. According To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Iron Carboxymaltose (Atc Code According To Who: B03Ac; Official Atc: B03Ac01)
country Germany
posting date21 Dec 2023
deadline31 Jan 2026
Medicines With The Active Ingredient Iron Carboxymaltose (Atc: B03Ac01)
country Germany
posting date13 Oct 2023
deadline30 Sep 2025
Ferric Carboxymaltose 50Mg Per 1Ml Inj - 10Ml
country India
posting date23 May 2025
deadline30 May 2025
Inj. Ondansetron 2Mg Per Ml 2 Ml. Amp. , Inj. Pantoprazole40Mg Vial With 10 Ml Normal Saline Ip Ampoule , Inj.Hydrocortisone Sodium Succinate 100Mg Vial With 5 Ml Wfiampoule , Inj. Dexamethasone 4 Mg Per Ml 2 Ml. Vial Orampoule , Inj. Ferric Carboxymaltose 500 Mg Per 10 Ml 10Ml. Vial , Inj. Levetiracetam 100Mg Per Ml 5 Ml. Vial , Inj.Phenytoin 50 Mg. Per Ml 2 Ml. Ampoule , Inj. Tranexamicacid 500Mg Per 5 Ml 5 Ml. Ampoule , Inj. Levocarnitine 200Mg. Per Ml 5 Ml. Ampoule Quantity: 105500
country India
posting date23 May 2025
deadline12 Jun 2025
Ferric Carboxymaltose 50Mg Per 1Ml Inj - 10Ml
country India
posting date17 May 2025
deadline02 Jun 2025
Alfuzosin 10 Mg Tab , Inj Ferric Carboxymaltose 50Mg Ml 10Ml Vial , Inj Human Insulin Analogue Glargine Recombinantdna Origin 450 Iu 1.5 Ml Pfs Disposable Pen With 5 Needlesper Pen , Inj Human Insulin Analogue Rapid Acting 100 Iu Mlrecombinant Dna Origin 300Iu Disposable Pen With 5Needles Per Pen , Inj Insuline Biphasic Isophen 30 70 ,Insulin Premixed Biphasic 40 Iu Per Ml 30 Human Neutralplus 70 Human Isophane Insulin 10 Ml Inj , Inj Tetanustoxoid 5 Ml , Inj Teriparatide 750 Mcg 3Ml , Bimatoprost0.03 Percent Bott Of 3Ml , Brimonidine 0.2 Timolol 0.5 Eyedrops Bottle Of 5Ml , Brinzalomide Benzalkonium Chloride Ipas Preservative 0.01 W V Aqueous Eye Drops Bottle Of 5 Ml ,Cap Alfacalcidol Vit D3 0.25 Mcg , Cap Amoxycillin 250 Mg ,Cap Gabapentin 300 Mg , Cap Pregabalin 75Mg , Captamsulosin Hcl 0.4 Mg , Carbidopa 10 Mg Levodopa 100Mg Tab Quantity: 19088
country India
posting date17 May 2025
deadline07 Jun 2025

Share Share this page